$VICR

VINCIARELLI PATRIZIO sold $133K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 400 shares of VICOR CORP (VICR) at $332.20 ($0.13M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 4, 2026, 6:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 6:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure can influence short-term sentiment, but the 10b5-1 structure typically lowers the inference that the insider is reacting to new negative information.

02

Market read

A routine insider sell at a specified price and date, disclosed via Form 4, with limited fundamental implications due to 10b5-1 pre-arrangement.

03

What to watch

Assess whether there are multiple recent Form 4 sales by the same insider or other insiders; one isolated sale is less informative.

Relevance 6/10Novelty 4/10Timing: Filed today; reflects a sale executed on 2026-06-03.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by VICR’s Chairman/CEO under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold $132.9K of VICR shares via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any move is likely sentiment-driven and should fade unless follow-on selling accelerates.

Evidence & confidence

The filing is a routine Form 4 datapoint (small value vs. large holdings) and explicitly references a pre-arranged 10b5-1 plan, reducing signaling risk.

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider selling under a 10b5-1 plan can be purely mechanical (tax/portfolio rebalancing) and may not reflect bearish fundamentals.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; sold 400 shares at $332.1975/share.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: